Professor Grygier, Poznan University of Medical Sciences Team and the CroíValve Team following DUO Adapt cases Dublin, Ireland, June 23, 2026 – CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of tricuspid regurgitation, announced today the closing of $20 million Series B expansion financing, along … Continue reading CroíValve Announces Expansion of Series B Financing with $27 Million Additional Capital to Fund DUO Adapt in an Enlarged TANDEM II Study